Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
05/22/2015 05/26/2015 05/27/2015 05/28/2015 05/29/2015 Date
62.408(c) 63.99(c) 63.12(c) 63.243(c) 63.85(c) Last
0 10 224 0 30 Volume
+0.15% +2.53% -1.36% +0.19% +0.96% Change
More quotes
Financials (€)
Sales 2015 3 652 M
EBIT 2015 516 M
Net income 2015 283 M
Debt 2015 1 502 M
Yield 2015 1,78%
Sales 2016 3 952 M
EBIT 2016 660 M
Net income 2016 392 M
Debt 2016 1 356 M
Yield 2016 1,94%
PER 2015 41,40
PER 2016 30,30
EV / Sales 2015 3,88x
EV / Sales 2016 3,55x
Capitalization 12 662 M
More Financials
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
07/30Earnings Release
More about the company
Surperformance© ratings of UCB SA
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB SA
05/27 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Salts (..
05/04 UCB : ex-dividend day for annual dividend
04/02 DR REDDY LABORATORIES : Labs to Acquire Brands Portfolio of UCB for USD128 Milli..
03/30 Ireland's Horizon to buy U.S. drugmaker Hyperion for $1.1 billion
03/27 UCB : Convening notice to attend the general meeting of shareholders
03/25 UCB : Findings from UCB Pharma SA Yields New Findings on Toxicology (Identificat..
02/12 UCB : Patent Issued for Systems for Administering Medication
02/12 UCB : Patent Issued for Syringe Safety Assembly
More news
Sector news : Biopharmaceuticals
07:38a ROCHE BEARER SHARE : Collaborative group phase III study shows Roche’s Ava..
07:38a ROCHE BEARER SHARE : Updated data showed Roche’s investigational combinati..
07:31a PFIZER : Announces Palbociclib More Than Doubled Progression-Free Survival in Ph..
More sector news : Biopharmaceuticals
Comments 
Advertisement
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions